Company Information

Orexo US, Inc.

Member Type

Associate

Organization Type

Manufacturer

Description

Orexo is a specialty pharma company with commercial operations in the United States and R&D in Sweden developing improved treatments using proprietary drug delivery technology. The company is commercializing its proprietary product, ZUBSOLV® sublingual tablets, for maintenance treatment of opioid dependence, in the United States. The ZUBSOLV sublingual tablet is a novel formulation of buprenorphine and naloxone using Orexo’s extensive knowledge in sublingual technologies. Orexo has a portfolio of two approved and revenue generating products currently marketed under license in the US, EU and Japan.

Contact Information

150 Headquarters Plaza, East Tower, 5th Floor

Morristown, NJ 07960

(855)673-9687

Services Offered

Branded

Staff

• DeLuca, Robert

  President, Orexo US, Inc.

• Safran, Craig

  Vice President, Commercial Operations, Orexo US, Inc.